Duncker Streett & Co’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.69M Buy
5,580
+4,901
+722% +$5.01M 1.13% 21
2026
Q1
$624K Sell
679
-11
-2% -$11.2K 0.12% 143
2025
Q4
$742K Sell
690
-82
-11% -$78.4K 0.13% 120
2025
Q3
$589K Buy
772
+11
+1% +$8.19K 0.1% 138
2025
Q2
$593K Hold
761
0.11% 144
2025
Q1
$628K Sell
761
-99
-12% -$82.4K 0.12% 132
2024
Q4
$664K Sell
860
-39
-4% -$32.3K 0.12% 130
2024
Q3
$797K Buy
899
+7
+0.8% +$6.29K 0.15% 123
2024
Q2
$808K Hold
892
0.16% 119
2024
Q1
$694K Buy
892
+202
+29% +$144K 0.14% 129
2023
Q4
$402K Buy
690
+1
+0.1% +$584 0.08% 166
2023
Q3
$370K Hold
689
0.09% 160
2023
Q2
$323K Sell
689
-18
-3% -$7.55K 0.07% 182
2023
Q1
$243K Hold
707
0.06% 190
2022
Q4
$259K Hold
707
0.06% 190
2022
Q3
$229K Hold
707
0.06% 196
2022
Q2
$229K Hold
707
0.05% 207
2022
Q1
$202K Buy
707
+1
+0.1% +$257 0.04% 228
2021
Q4
$195K Sell
706
-183
-21% -$46.4K 0.03% 245
2021
Q3
$205K Sell
889
-389
-30% -$96K 0.04% 232
2021
Q2
$293K Hold
1,278
0.05% 208
2021
Q1
$239K Sell
1,278
-200
-14% -$39.1K 0.05% 223
2020
Q4
$249K Sell
1,478
-559
-27% -$83.5K 0.05% 215
2020
Q3
$302K Buy
2,037
+300
+17% +$46.4K 0.07% 198
2020
Q2
$285K Sell
1,737
-249
-13% -$38.2K 0.07% 197
2020
Q1
$276K Buy
1,986
+1
+0.1% +$137 0.07% 203
2019
Q4
$261K Hold
1,985
0.05% 233
2019
Q3
$222K Buy
1,985
+1
+0.1% +$111 0.05% 242
2019
Q2
$220K Sell
1,984
-400
-17% -$47.1K 0.05% 246
2019
Q1
$309K Buy
2,384
+401
+20% +$48.8K 0.07% 224
2018
Q4
$230K Hold
1,983
0.06% 230
2018
Q3
$213K Buy
1,983
+1
+0.1% +$100 0.05% 256
2018
Q2
$169K Hold
1,982
0.04% 269
2018
Q1
$153K Buy
1,982
+1
+0.1% +$81 0.04% 276
2017
Q4
$167K Buy
1,981
+1
+0.1% +$85 0.04% 273
2017
Q3
$169K Hold
1,980
0.05% 258
2017
Q2
$163K Buy
1,980
+1
+0.1% +$82 0.05% 261
2017
Q1
$166K Hold
1,979
0.05% 261
2016
Q4
$146K Buy
1,979
+1
+0.1% +$74 0.05% 267
2016
Q3
$159K Buy
1,978
+184
+10% +$14.7K 0.06% 253
2016
Q2
$141K Hold
1,794
0.05% 257
2016
Q1
$129K Sell
1,794
-464
-21% -$35.1K 0.05% 259
2015
Q4
$190K Buy
2,258
+1
+0% +$83 0.07% 233
2015
Q3
$189K Hold
2,257
0.07% 238
2015
Q2
$188K Buy
2,257
+1
+0% +$76 0.07% 248
2015
Q1
$164K Hold
2,256
0.05% 258
2014
Q4
$156K Buy
2,256
+1
+0% +$67 0.05% 268
2014
Q3
$146K Buy
2,255
+165
+8% +$10.4K 0.05% 271
2014
Q2
$130K Buy
2,090
+390
+23% +$23.3K 0.04% 302
2014
Q1
$100K Sell
1,700
-1,556
-48% -$86.8K 0.04% 307
2013
Q4
$166K Buy
3,256
+700
+27% +$35.1K 0.06% 256
2013
Q3
$129K Hold
2,556
0.05% 264
2013
Q2
$126K Buy
+2,556
New +$139K 0.05% 273

Other funds holding LLY

Duncker Streett & Co's LLY Position: Q2 2026 in Review

Duncker Streett & Co increased its Eli Lilly (LLY) stake by 722% in Q2 2026, buying an estimated $5.01M and bringing the position to 5,580 shares worth $6.69M. The position accounts for 1.13% of the portfolio, ranked #21.

Duncker Streett & Co first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Duncker Streett & Co held 5,580 shares of Eli Lilly worth $6.69M as of Q2 2026.
  • Duncker Streett & Co bought 4,901 Eli Lilly shares in Q2 2026, an estimated $5.01M.
  • Eli Lilly made up 1.13% of Duncker Streett & Co's portfolio in Q2 2026, its #21 holding.
  • Duncker Streett & Co first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Duncker Streett & Co's 13F filing for Q2 2026, filed 28 Jul 2026.